Labi Exames

Name

Labi Exames

Website

https://labiexames.com.br

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Diagnostic Laboratory Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Central Laboratory Services (Core Lab Operations) (HLAGAEAA)

akta.pro secondary industry

Clinical Research & Trial Central Laboratories (HLAFAMAL)

Keywords

• Diagnostic laboratory services
• Clinical blood testing
• Home sample collection
• Immunobiological infusions
• Direct-to-consumer lab tests

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Laboratory Test Services: One-time transaction-based revenue from individual laboratory tests purchased by consumers directly through website, app, or at physical units. Also accepts health insurance plans for covered tests.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Labi Exames (operating as Labi Saúde) is a Brazilian diagnostic laboratory company that provides clinical laboratory tests directly to consumers without requiring a doctor's prescription. Services can be purchased through the website, mobile app, or at physical collection units located near metro stations. The company also offers at-home blood sample collection for orders starting at R$ 250 and administration of immunobiological medications.

Product overview

Labi Exames (Labi Saúde) is a laboratory testing company offering a unified service platform for clinical diagnostic tests. The core product is laboratory testing services (Exames Laboratoriais), complemented by home collection services (Coleta Domiciliar), infusion services (Infusões) for immunobiological medication administration, and commented medical reports (Laudo Comentado). Tests can be purchased online, via app, or in-person at modern units near metro stations, with results accessible through the website.

Differentiator

Problem solved

Functional benefit

Products and services

• Exames Laboratoriais (Laboratory Tests)
• Coleta Domiciliar (Home Collection)
• Infusões (Infusions)

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Dasa: Largest integrated diagnostics company in Brazil, operating a national network of clinical labs and hospital diagnostics. Comparable because it offers the same routine test catalog to consumers and health plans, but at much greater scale and through B2B2C channels.
• Fleury: Major Brazilian clinical laboratory chain with premium positioning and broad health-plan relationships. Comparable because it serves overlapping consumer test needs in São Paulo and other major metros, with an established brand Labi must compete against.
• Sabin Diagnóstico e Saúde: Brazilian diagnostics chain offering clinical lab tests, imaging, and outpatient services across multiple states. Comparable because it sells the same routine exam catalog to consumers, though through a more traditional B2B2C model.
• Delboni Auriemo: São Paulo–based clinical laboratory brand (part of Dasa) operating in Labi's home geography. Comparable because it serves the same urban São Paulo consumer for routine diagnostic tests and competes for the same foot-traffic and prescription-driven demand.
• Hermes Pardini: Brazilian diagnostics network (part of Dasa) covering Minas Gerais and other regions with clinical lab and imaging services. Comparable because it sells overlapping routine lab tests to consumers and corporate clients through its own unit network.
• Diagnósticos da América (Dasa consumer brands): Dasa's consumer-facing brands (e.g., a+ , Delboni, Lavoisier) that increasingly offer digital booking, home collection, and prescription-free tests. Comparable to Labi because incumbents are actively copying Labi's DTC playbook at much greater scale.

Direct peers

• Dr. Consulta: Brazilian digital health platform offering affordable outpatient consultations and lab tests to consumers without health plans. Directly comparable to Labi because of overlapping low-cost, cash-pay, digital-first D2C model targeting underinsured Brazilian consumers.
• Beep Saúde: Brazilian DTC health services startup offering at-home sample collection and lab testing booked via app. Most directly comparable to Labi because both offer prescription-free tests via mobile app with home collection, targeting similar price-sensitive urban consumers.

Emerging players

• Hilab: Brazilian digital diagnostics startup offering connected rapid-testing devices and online lab test ordering. Comparable to Labi because it targets the same prescription-free, app-driven consumer testing niche, though with proprietary point-of-care hardware rather than traditional venipuncture collection units.
• Alliança Saúde: Brazilian diagnostic medicine group with lab and imaging services across multiple states. Comparable because it competes in routine clinical lab testing for Brazilian consumers and health plans, though with a more regional rather than DTC focus.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds3 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Labi Exames